Dr. Michael Flynn
Overview
Michael Flynn is a primary care provider, practicing in Internal Medicine in Midvale, Utah. Dr. Flynn is highly rated in 2 conditions, according to our data. His top areas of expertise are Maturity Onset Diabetes of the Young, End-Stage Renal Disease (ESRD), Type 2 Diabetes (T2D), and Chronic Cough. Dr. Flynn is currently accepting new patients.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7495 S State St, Midvale, UT 84047
5126 W Daybreak Pkwy Ste 600, South Jordan, UT 84009
Taylorsville, UT 84129
26 S Main St, Centerville, UT 84014
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Imed Physicians
PATIENT EDUCATION VIDEOSDr. Woller’s academic interests reside in thrombosis medicine and anticoagulation management. With a particular interest in the prevention of venous thromboembolic disease, Dr. Woller has served as investigator on multiple ongoing and completed clinical trials including the NIH-funded studies. Dr. Woller is Co-Chair for the American College of Chest Physicians (ACCP) Clinical Practice Guideline that addresses antithrombotic therapy for venous thromboembolic disease, and as was a panelist for the Vascular Access Appropriateness Panel housed at the University of Michigan. Dr. Woller is an invited panelist for the Centers for Disease Control and Prevention (CDC) Risk Assessment Model for the Prevention of Venous Thromboembolic Disease in Medical Patients program. Dr. Woller is Professor of Medicine, University of Utah School of Medicine, Professor in Research, Intermountain Healthcare, and is a recognized teacher and recipient of the Intermountain Medical Center Housestaff Teaching Award (2011), the University of Utah School of Medicine Outstanding Faculty Teaching Award (2012), and the University of Utah Department of Internal Medicine Outstanding Faculty Subspecialty Teaching Award (2021, 2024). Dr. Woller, Fellow of the American College of Chest Physicians (FCCP) and Fellow of the American College of Physicians (FACP), served as Utah Chapter Governor of the American College of Physicians (Class of 2025). Dr. Woller's research group was awarded the 2015 U.S. Centers for Disease Control and Prevention (CDC) Healthcare-Associated Venous Thromboembolism (HA-VTE) Prevention Challenge Award. It was with sincere humility and gratitude that Dr. Woller received the Intermountain Health Patient Experience Award (2022, 2024). Dr. Woller received his medical degree from Northwestern University Medical School in 2000. Dr. Woller completed his residency at the University of Utah Hospital (2003) then served as Chief Medical Resident in 2003-04. Dr. Woller is Board Certified in Internal Medicine and attends at the Intermountain Medical Center, Murray UT. Dr. Woller is highly rated in 5 conditions, according to our data. His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Thrombectomy, and Knee Replacement.
Gen. Med. Division - Sugarhouse
Andrew Chang is an Internal Medicine provider in Salt Lake City, Utah. Dr. Chang has been practicing medicine for over 18 years is highly rated in 3 conditions, according to our data. His top areas of expertise are Diabetic Macular Edema (DME), Aspergillosis, Vitrectomy, and Cataract Removal. Dr. Chang is currently accepting new patients.
Lucinda Bateman is a primary care provider, practicing in Internal Medicine in Murray, Utah. Dr. Bateman is highly rated in 4 conditions, according to our data. Her top areas of expertise are Fibromyalgia, Chronic Fatigue Syndrome, Mononucleosis, and Long Haul COVID. Dr. Bateman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- End-Stage Renal Disease (ESRD)Dr. Flynn isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Maturity Onset Diabetes of the Young
- Experienced
- Aplastic AnemiaDr. Flynn isExperienced. Learn about Aplastic Anemia.
- Cerebral HypoxiaDr. Flynn isExperienced. Learn about Cerebral Hypoxia.
- Chronic CoughDr. Flynn isExperienced. Learn about Chronic Cough.
- Chronic Kidney DiseaseDr. Flynn isExperienced. Learn about Chronic Kidney Disease.
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Hyperglycemic Hyperosmolar Syndrome